Priority Date: 26.03.10 (US 20100318105P)

METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS USING N6 - CYCLOPENTYLADENOSINE (CPA), CPA DERIVATIVES OR PRODRUGS THEREOF

  • Application ID: EP11760319
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorney

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 26.03.2010 - Priority Date (US 20100318105P)
  • 29.09.2011 - Publication A1 (WO2011119969)
  • 20.03.2013 - Publication A1 (EP2569325)